Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Effects of Resistance Exercise and Nutritional Supplementation on Dynamic Cerebral Autoregulation in Head-Down Bed Rest.

Kermorgant M, Nasr N, Custaud MA, Navasiolava N, Arbeille P, Guinet P, Labrunée M, Besnier F, Arvanitis DN, Czosnyka M, Senard JM, Pavy-Le Traon A.

Front Physiol. 2019 Aug 27;10:1114. doi: 10.3389/fphys.2019.01114. eCollection 2019.

2.

Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial.

Besnier F, Labrunée M, Richard L, Faggianelli F, Kerros H, Soukarié L, Bousquet M, Garcia JL, Pathak A, Gales C, Guiraud T, Sénard JM.

Ann Phys Rehabil Med. 2019 Sep;62(5):321-328. doi: 10.1016/j.rehab.2019.06.013. Epub 2019 Jul 25.

PMID:
31352063
3.

Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor.

Garcia C, Maurel-Ribes A, Nauze M, N'Guyen D, Martinez LO, Payrastre B, Sénard JM, Galés C, Pons V.

Cell Mol Life Sci. 2019 Feb;76(3):561-576. doi: 10.1007/s00018-018-2960-3. Epub 2018 Nov 7.

PMID:
30406277
4.

Structural evidence for a new elaborate 3D-organization of the cardiomyocyte lateral membrane in adult mammalian cardiac tissues.

Guilbeau-Frugier C, Cauquil M, Karsenty C, Lairez O, Dambrin C, Payré B, Cassard H, Josse C, Seguelas MH, Allart S, Branchereau M, Heymes C, Mandel F, Delisle MB, Pathak A, Dague E, Sénard JM, Galés C.

Cardiovasc Res. 2019 May 1;115(6):1078-1091. doi: 10.1093/cvr/cvy256.

PMID:
30329023
5.

In memoriam: Sir Roger Bannister 1929-2018.

Struhal W, Thijs RD, Pavy-Le Traon A, Wenning G, Senard JM.

Clin Auton Res. 2018 Jun;28(3):351. doi: 10.1007/s10286-018-0535-x. Epub 2018 May 30. No abstract available.

PMID:
29846822
6.

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients.

Matta M, Pavy-Le Traon A, Perez-Lloret S, Laporte C, Berdugo I, Nasr N, Hanaire H, Senard JM.

J Diabetes Res. 2018 Mar 5;2018:5601351. doi: 10.1155/2018/5601351. eCollection 2018.

7.

Intracranial Pressure Is a Determinant of Sympathetic Activity.

Schmidt EA, Despas F, Pavy-Le Traon A, Czosnyka Z, Pickard JD, Rahmouni K, Pathak A, Senard JM.

Front Physiol. 2018 Feb 8;9:11. doi: 10.3389/fphys.2018.00011. eCollection 2018.

8.

Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease.

Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, Ory-Magne F, Rascol O, Senard JM.

Neurophysiol Clin. 2018 Apr;48(2):103-110. doi: 10.1016/j.neucli.2017.11.003. Epub 2017 Dec 14.

PMID:
29249575
9.

Impacts of Simulated Weightlessness by Dry Immersion on Optic Nerve Sheath Diameter and Cerebral Autoregulation.

Kermorgant M, Leca F, Nasr N, Custaud MA, Geeraerts T, Czosnyka M, Arvanitis DN, Senard JM, Pavy-Le Traon A.

Front Physiol. 2017 Oct 12;8:780. doi: 10.3389/fphys.2017.00780. eCollection 2017.

10.

G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning.

Onfroy L, Galandrin S, Pontier SM, Seguelas MH, N'Guyen D, Sénard JM, Galés C.

Sci Rep. 2017 Aug 11;7(1):7885. doi: 10.1038/s41598-017-07392-5.

12.

Nanoscale structural mapping as a measure of maturation in the murine frontal cortex.

Smolyakov G, Dague E, Roux C, Seguelas MH, Galés C, Senard JM, Arvanitis DN.

Brain Struct Funct. 2018 Jan;223(1):255-265. doi: 10.1007/s00429-017-1486-z. Epub 2017 Aug 4.

PMID:
28779306
13.

Biophysical properties of cardiomyocyte surface explored by multiparametric AFM.

Smolyakov G, Cauquil M, Severac C, Lachaize V, Guilbeau-Frugier C, Sénard JM, Galés C, Dague E.

J Struct Biol. 2017 Apr;198(1):28-37. doi: 10.1016/j.jsb.2017.03.001. Epub 2017 Mar 2.

PMID:
28263874
14.

Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.

Galandrin S, Denis C, Boularan C, Marie J, M'Kadmi C, Pilette C, Dubroca C, Nicaise Y, Seguelas MH, N'Guyen D, Banères JL, Pathak A, Sénard JM, Galés C.

Hypertension. 2016 Dec;68(6):1365-1374. Epub 2016 Oct 3.

PMID:
27698068
15.

Whole-body strength training with Huber Motion Lab and traditional strength training in cardiac rehabilitation: A randomized controlled study.

Guiraud T, Labrunée M, Besnier F, Sénard JM, Pillard F, Rivière D, Richard L, Laroche D, Sanguignol F, Pathak A, Gayda M, Gremeaux V.

Ann Phys Rehabil Med. 2017 Jan;60(1):20-26. doi: 10.1016/j.rehab.2016.07.385. Epub 2016 Sep 16.

16.

Exercise training-induced modification in autonomic nervous system: An update for cardiac patients.

Besnier F, Labrunée M, Pathak A, Pavy-Le Traon A, Galès C, Sénard JM, Guiraud T.

Ann Phys Rehabil Med. 2017 Jan;60(1):27-35. doi: 10.1016/j.rehab.2016.07.002. Epub 2016 Aug 16. Review.

17.

Delineating biased ligand efficacy at 7TM receptors from an experimental perspective.

Galandrin S, Onfroy L, Poirot MC, Sénard JM, Galés C.

Int J Biochem Cell Biol. 2016 Aug;77(Pt B):251-63. doi: 10.1016/j.biocel.2016.04.009. Epub 2016 Apr 21. Review.

PMID:
27107932
18.

Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.

Hijona E, Aguirre L, Pérez-Matute P, Villanueva-Millán MJ, Mosqueda-Solis A, Hasnaoui M, Nepveu F, Senard JM, Bujanda L, Aldámiz-Echevarría L, Llarena M, Andrade F, Perio P, Leboulanger F, Hijona L, Arbones-Mainar JM, Portillo MP, Carpéné C.

J Physiol Biochem. 2016 Sep;72(3):567-82. doi: 10.1007/s13105-015-0464-2. Epub 2016 Jan 20.

PMID:
26792656
19.

Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity.

Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard JM, Fajadet J, Mahfoud F.

EuroIntervention. 2015 Aug;11(4):477-84. doi: 10.4244/EIJV11I4A96.

20.

Improved Walking Claudication Distance with Transcutaneous Electrical Nerve Stimulation: An Old Treatment with a New Indication in Patients with Peripheral Artery Disease.

Labrunée M, Boned A, Granger R, Bousquet M, Jordan C, Richard L, Garrigues D, Gremeaux V, Sénard JM, Pathak A, Guiraud T.

Am J Phys Med Rehabil. 2015 Nov;94(11):941-9. doi: 10.1097/PHM.0000000000000277.

PMID:
25802954
21.

Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling.

Bellot M, Galandrin S, Boularan C, Matthies HJ, Despas F, Denis C, Javitch J, Mazères S, Sanni SJ, Pons V, Seguelas MH, Hansen JL, Pathak A, Galli A, Sénard JM, Galés C.

Nat Chem Biol. 2015 Apr;11(4):271-9. doi: 10.1038/nchembio.1766. Epub 2015 Feb 23.

22.

Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.

Gargiulo L, Copsel S, Rivero EM, Galés C, Sénard JM, Lüthy IA, Davio C, Bruzzone A.

Oncotarget. 2014 Oct 30;5(20):10058-69.

23.

Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure.

Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C, Payré B, Chopinet L, Alsteens D, Kasas S, Severac C, Thireau J, Heymes C, Honton B, Lacampagne A, Pathak A, Sénard JM, Galés C.

J Mol Cell Cardiol. 2014 Sep;74:162-72. doi: 10.1016/j.yjmcc.2014.05.006. Epub 2014 May 17.

PMID:
24839910
24.

Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy.

Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, Labrunee M, Guiraud T, Esler M, Galinier M, Senard JM, Pathak A.

PLoS One. 2014 Mar 25;9(3):e93278. doi: 10.1371/journal.pone.0093278. eCollection 2014.

25.

Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals.

Bruzzone A, Saulière A, Finana F, Sénard JM, Lüthy I, Galés C.

FASEB J. 2014 Mar;28(3):1342-54. doi: 10.1096/fj.13-239285. Epub 2013 Dec 5.

PMID:
24308976
26.

Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study).

Labrunée M, Despas F, Marque P, Guiraud T, Galinier M, Senard JM, Pathak A.

PLoS One. 2013 Nov 12;8(11):e79438. doi: 10.1371/journal.pone.0079438. eCollection 2013.

27.

Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stability.

Mias C, Coatrieux C, Denis C, Genet G, Seguelas MH, Laplace N, Rouzaud-Laborde C, Calise D, Parini A, Cussac D, Pathak A, Sénard JM, Galés C.

PLoS One. 2013 Nov 14;8(11):e79068. doi: 10.1371/journal.pone.0079068. eCollection 2013.

28.

Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis.

Dumonteil N, Vaccaro A, Despas F, Labrunee M, Marcheix B, Lambert E, Esler M, Carrie D, Senard JM, Galinier M, Pathak A.

JACC Cardiovasc Interv. 2013 Nov;6(11):1195-202. doi: 10.1016/j.jcin.2013.06.012. Epub 2013 Oct 16.

29.

Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.

Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F.

J Clin Pharm Ther. 2013 Oct;38(5):341-9. doi: 10.1111/jcpt.12067. Epub 2013 Apr 18. Review.

PMID:
23594161
30.

High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure.

Guiraud T, Labrunee M, Gaucher-Cazalis K, Despas F, Meyer P, Bosquet L, Gales C, Vaccaro A, Bousquet M, Galinier M, Sénard JM, Pathak A.

Med Sci Sports Exerc. 2013 Oct;45(10):1861-7. doi: 10.1249/MSS.0b013e3182967559.

PMID:
23591293
31.

Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity.

Franchitto N, Despas F, Labrunee M, Vaccaro A, Lambert E, Lambert G, Galinier M, Senard JM, Pathak A.

Int J Cardiol. 2013 Oct 3;168(3):2352-7. doi: 10.1016/j.ijcard.2013.01.023. Epub 2013 Feb 13.

PMID:
23415171
32.

[Adult resident cardiomyocytes wake up: new axis for cardiac tissue regeneration].

Mias C, Genet G, Pathak A, Sénard JM, Galés C.

Med Sci (Paris). 2012 Dec;28(12):1103-9. doi: 10.1051/medsci/20122812021. Epub 2012 Dec 21. Review. French.

33.

[Central autonomic failures].

Senard JM, Despas F, Pathak A.

Presse Med. 2012 Nov;41(11):1122-7. doi: 10.1016/j.lpm.2012.04.028. Epub 2012 Aug 13. Review. French.

PMID:
22898130
34.

[Cardiotoxicity of chemotherapies].

Castel M, Despas F, Modesto A, Gales C, Honton B, Galinier M, Senard JM, Pathak A.

Presse Med. 2013 Jan;42(1):26-39. doi: 10.1016/j.lpm.2012.04.014. Epub 2012 Jun 21. Review. French.

PMID:
22727981
35.

Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

Saulière A, Bellot M, Paris H, Denis C, Finana F, Hansen JT, Altié MF, Seguelas MH, Pathak A, Hansen JL, Sénard JM, Galés C.

Nat Chem Biol. 2012 Jul;8(7):622-30. doi: 10.1038/nchembio.961. Epub 2012 May 27.

PMID:
22634635
36.

Factors related to orthostatic hypotension in Parkinson's disease.

Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Senard JM, Pavy-Le Traon A, Montastruc JL, Rascol O.

Parkinsonism Relat Disord. 2012 Jun;18(5):501-5. doi: 10.1016/j.parkreldis.2012.01.012. Epub 2012 Feb 13.

PMID:
22336566
37.

Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion.

Genet G, Guilbeau-Frugier C, Honton B, Dague E, Schneider MD, Coatrieux C, Calise D, Cardin C, Nieto C, Payré B, Dubroca C, Marck P, Heymes C, Dubrac A, Arvanitis D, Despas F, Altié MF, Seguelas MH, Delisle MB, Davy A, Sénard JM, Pathak A, Galés C.

Circ Res. 2012 Mar 2;110(5):688-700. doi: 10.1161/CIRCRESAHA.111.262451. Epub 2012 Feb 2.

38.

Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure.

Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard JM, Lambert G, Esler M, Pathak A.

J Hypertens. 2012 Apr;30(4):753-60. doi: 10.1097/HJH.0b013e328350136c.

PMID:
22241144
39.

Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.

Damon-Perrière N, Foubert-Samier A, De Cock VC, Gerdelat-Mas A, Debs R, Pavy-Le Traon A, Senard JM, Rascol O, Tison F, Meissner WG.

Parkinsonism Relat Disord. 2012 Jun;18(5):612-5. doi: 10.1016/j.parkreldis.2011.12.009. Epub 2012 Jan 9.

PMID:
22236582
40.

Probing heterotrimeric G protein activation: applications to biased ligands.

Denis C, Saulière A, Galandrin S, Sénard JM, Galés C.

Curr Pharm Des. 2012;18(2):128-44. Review.

41.

[Proton pump inhibitors: impact of professional practice evaluation on prescriptions pertinence].

Fuzier R, Maguès JP, Dupuis E, Pomiès S, Segui S, Sénard JM.

Ann Fr Anesth Reanim. 2011 Nov;30(11):814-8. doi: 10.1016/j.annfar.2011.07.004. Epub 2011 Oct 5. French.

PMID:
21981846
42.

G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors.

Maïga A, Mourier G, Quinton L, Rouget C, Gales C, Denis C, Lluel P, Sénard JM, Palea S, Servent D, Gilles N.

Toxicon. 2012 Mar 15;59(4):487-96. doi: 10.1016/j.toxicon.2011.03.009. Epub 2011 Mar 22.

PMID:
21419153
43.

Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment?

Senard JM, Pathak A.

Rev Neurol (Paris). 2010 Oct;166(10):779-84. doi: 10.1016/j.neurol.2010.07.007. Review.

PMID:
20817229
44.

Cardiovascular autonomic neuropathy and other complications in type 1 diabetes.

Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H.

Clin Auton Res. 2010 Jun;20(3):153-60. doi: 10.1007/s10286-010-0062-x. Epub 2010 Mar 31.

PMID:
20354891
45.

Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Montastruc JL, Danton AC, Durrieu G, Lacroix I, Olivier P, Sommet A, Senard JM; French Association of Regional, PharmacoVigilance Centres.

Mov Disord. 2010 Apr 15;25(5):660-1. doi: 10.1002/mds.22878. No abstract available.

PMID:
20213824
46.

Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia.

Franchitto N, Despas F, Labrunée M, Roncalli J, Boveda S, Galinier M, Senard JM, Pathak A.

Hypertension. 2010 Apr;55(4):1012-7. doi: 10.1161/HYPERTENSIONAHA.109.146779. Epub 2010 Mar 1.

PMID:
20194300
47.

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Despas F, Pathak A, Berry M, Cagnac R, Massabuau P, Liozon E, Galinier M, Senard JM.

Clin Auton Res. 2010 Jun;20(3):205-7. doi: 10.1007/s10286-009-0049-7. Epub 2010 Jan 9.

PMID:
20063034
48.

Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure.

Despas F, Guerriero E, Galinier M, Senard J, Pathak A.

J Heart Lung Transplant. 2010 May;29(5):591-2. doi: 10.1016/j.healun.2009.10.017. Epub 2009 Dec 31. No abstract available.

PMID:
20044275
49.

Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.

Despas F, Trouillet C, Franchitto N, Labrunee M, Galinier M, Senard JM, Pathak A.

Acute Card Care. 2010 Mar;12(1):25-30. doi: 10.3109/17482940903434077.

PMID:
19929264
50.

Monitoring cognitive and emotional processes through pupil and cardiac response during dynamic versus logical task.

Causse M, Sénard JM, Démonet JF, Pastor J.

Appl Psychophysiol Biofeedback. 2010 Jun;35(2):115-23. doi: 10.1007/s10484-009-9115-0.

PMID:
19816770

Supplemental Content

Loading ...
Support Center